| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8825b6a4a1bc4d3d9b75f6734bb19a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c92af09e74d4038fb5309bbeda31818c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 |
| filingDate |
2005-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86537d66582a253154c4bd77e88d22db |
| publicationDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005074945-A3 |
| titleOfInvention |
Ketolide compounds for the treatment of atherosclerosis |
| abstract |
The present invention relates to the discovery that ketolide compounds such as telithromycin, are potent inhibitors of the lipid oxidation abzymes which play a key role in atherosclerotic conditions. Methods and uses of ketolide compounds, such as telithromycin, in the treatment of atherosclerotic conditions are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9453042-B2 |
| priorityDate |
2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |